CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 74 entries

View as:

PMCF Study for Peripheral Arteries Below the Knee (BTK)

Phase: N/A Priority: Normal

NCT ID: NCT05444660 Org: User:

Start: 05/05/22 End: 11/02/22 Due: 11/02/23

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease

Phase: N/A Priority: Normal

NCT ID: NCT00640770 Org: User:

Start: 03/31/08 End: 01/31/11 Due: 01/31/12

A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)

Phase: N/A Priority: Normal

NCT ID: NCT01664078 Org: User:

Start: 07/31/12 End: 10/10/18 Due: 10/10/19

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Phase: N/A Priority: Normal

NCT ID: NCT00322569 Org: User:

Start: 07/31/06 End: 05/31/12 Due: 05/31/13

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

Phase: N/A Priority: Normal

NCT ID: NCT00231283 Org: User:

Start: 04/30/04 End: 07/31/05 Due: 07/31/06

Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)

Phase: N/A Priority: Normal

NCT ID: NCT00231231 Org: User:

Start: 09/30/04 End: 11/30/06 Due: 11/30/07

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Phase: N/A Priority: Normal

NCT ID: NCT00232765 Org: User:

Start: 02/28/01 End: 11/30/08 Due: 11/30/09

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial

Phase: N/A Priority: Normal

NCT ID: NCT00497172 Org: User:

Start: 01/31/04 End: 04/30/09 Due: 04/30/10

Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions

Phase: N/A Priority: Normal

NCT ID: NCT00714883 Org: User:

Start: 06/30/08 End: 10/31/12 Due: 10/31/13

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions

Phase: N/A Priority: Normal

NCT ID: NCT00233714 Org: User:

Start: 05/31/03 End: 11/30/09 Due: 11/30/10

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.

Phase: N/A Priority: Normal

NCT ID: NCT00232856 Org: User:

Start: 12/31/02 End: 08/31/06 Due: 08/31/07

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)

Phase: N/A Priority: Normal

NCT ID: NCT01202058 Org: User:

Start: 08/31/10 End: 10/31/12 Due: 10/31/13

Compassionate Use of the Incraft® AAA Stent Graft System

Phase: N/A Priority: Normal

NCT ID: NCT01776450 Org: User:

Start: - End: - Due: -

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Phase: N/A Priority: Normal

NCT ID: NCT00165035 Org: User:

Start: 05/31/05 End: 07/31/11 Due: 07/31/12

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent

Phase: N/A Priority: Normal

NCT ID: NCT00235131 Org: User:

Start: 05/31/05 End: 05/31/09 Due: 05/31/10

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

Phase: N/A Priority: Normal

NCT ID: NCT00235092 Org: User:

Start: 08/31/03 End: 03/31/06 Due: 03/31/07

European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms

Phase: N/A Priority: Normal

NCT ID: NCT02477111 Org: User:

Start: 03/30/15 End: 12/09/21 Due: 12/09/22

Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)

Phase: N/A Priority: Normal

NCT ID: NCT00231244 Org: User:

Start: 03/31/02 End: 11/30/08 Due: 11/30/09

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.

Phase: N/A Priority: Normal

NCT ID: NCT00235144 Org: User:

Start: 03/31/01 End: 09/30/08 Due: 09/30/09

The Intra-Drug Eluting Stent (DES) Restenosis Study

Phase: N/A Priority: Normal

NCT ID: NCT00323895 Org: User:

Start: 03/31/06 End: 01/31/10 Due: 01/31/11

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Phase: N/A Priority: Normal

NCT ID: NCT00233818 Org: User:

Start: 02/29/00 End: 06/30/05 Due: 06/30/06

A Multi-center Post-Market Surveillance Registry

Phase: N/A Priority: Normal

NCT ID: NCT00438919 Org: User:

Start: 05/31/06 End: 12/31/09 Due: 12/31/10

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)

Phase: N/A Priority: Normal

NCT ID: NCT01106391 Org: User:

Start: 03/31/10 End: 10/31/16 Due: 10/31/17

The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)

Phase: N/A Priority: Normal

NCT ID: NCT00974181 Org: User:

Start: 01/31/04 End: 03/31/10 Due: 03/31/11

PMCF Study for Peripheral Arteries Above the Knee (ATK)

Phase: N/A Priority: Normal

NCT ID: NCT05312580 Org: User:

Start: 06/01/22 End: 11/07/22 Due: 11/07/23

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
PMCF Study for Peripheral Arteries Below the Knee (BTK)	NCT05444660	Cordis Corporation	user2@example.com	None	2022-05-05	2022-11-02	2023-11-02	-	-	2025-07-14
Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease	NCT00640770	Cordis Corporation	user2@example.com	None	2008-03-31	2011-01-31	2012-01-31	-	-	2025-07-14
A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)	NCT01664078	Cordis Corporation	user2@example.com	None	2012-07-31	2018-10-10	2019-10-10	-	-	2025-07-14
A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)	NCT00322569	Cordis Corporation	user2@example.com	None	2006-07-31	2012-05-31	2013-05-31	-	-	2025-07-14
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions	NCT00231283	Cordis Corporation	user2@example.com	None	2004-04-30	2005-07-31	2006-07-31	-	-	2025-07-14
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)	NCT00231231	Cordis Corporation	user2@example.com	None	2004-09-30	2006-11-30	2007-11-30	-	-	2025-07-14
Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)	NCT00232765	Cordis Corporation	user2@example.com	None	2001-02-28	2008-11-30	2009-11-30	-	-	2025-07-14
Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial	NCT00497172	Cordis Corporation	user2@example.com	None	2004-01-31	2009-04-30	2010-04-30	-	-	2025-07-14
Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions	NCT00714883	Cordis Corporation	user2@example.com	None	2008-06-30	2012-10-31	2013-10-31	-	-	2025-07-14
Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions	NCT00233714	Cordis Corporation	user2@example.com	None	2003-05-31	2009-11-30	2010-11-30	-	-	2025-07-14
A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.	NCT00232856	Cordis Corporation	user2@example.com	None	2002-12-31	2006-08-31	2007-08-31	-	-	2025-07-14
An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)	NCT01202058	Cordis Corporation	user2@example.com	None	2010-08-31	2012-10-31	2013-10-31	-	-	2025-07-14
Compassionate Use of the Incraft® AAA Stent Graft System	NCT01776450	Cordis Corporation	user2@example.com	None	-	-	-	-	-	2025-07-14
Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)	NCT00165035	Cordis Corporation	user2@example.com	None	2005-05-31	2011-07-31	2012-07-31	-	-	2025-07-14
The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent	NCT00235131	Cordis Corporation	user2@example.com	None	2005-05-31	2009-05-31	2010-05-31	-	-	2025-07-14
The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus	NCT00235092	Cordis Corporation	user2@example.com	None	2003-08-31	2006-03-31	2007-03-31	-	-	2025-07-14
European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms	NCT02477111	Cordis Corporation	user2@example.com	None	2015-03-30	2021-12-09	2022-12-09	-	-	2025-07-14
Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)	NCT00231244	Cordis Corporation	user2@example.com	None	2002-03-31	2008-11-30	2009-11-30	-	-	2025-07-14
The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.	NCT00235144	Cordis Corporation	user2@example.com	None	2001-03-31	2008-09-30	2009-09-30	-	-	2025-07-14
The Intra-Drug Eluting Stent (DES) Restenosis Study	NCT00323895	Cordis Corporation	user2@example.com	None	2006-03-31	2010-01-31	2011-01-31	-	-	2025-07-14
FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent	NCT00233818	Cordis Corporation	user2@example.com	None	2000-02-29	2005-06-30	2006-06-30	-	-	2025-07-14
A Multi-center Post-Market Surveillance Registry	NCT00438919	Cordis Corporation	user2@example.com	None	2006-05-31	2009-12-31	2010-12-31	-	-	2025-07-14
A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)	NCT01106391	Cordis Corporation	user2@example.com	None	2010-03-31	2016-10-31	2017-10-31	-	-	2025-07-14
The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)	NCT00974181	Cordis Corporation	user2@example.com	None	2004-01-31	2010-03-31	2011-03-31	-	-	2025-07-14
PMCF Study for Peripheral Arteries Above the Knee (ATK)	NCT05312580	Cordis Corporation	user2@example.com	None	2022-06-01	2022-11-07	2023-11-07	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance